The effect of Liraglutide treatment on postprandial chylomicron and VLDL kinetics, liver fat and de novo lipogenesis. A single-center randomized controlled study.
Phase of Trial: Phase IV
Latest Information Update: 06 Mar 2017
At a glance
- Drugs Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms LIRA
- 07 Jun 2017 Biomarkers information updated
- 28 Feb 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Dec 2017.
- 15 Jul 2014 New trial record